# IBUPROFEN AND DIPHENHYDRAMINE CITRATE
> **ANDA211404** · Abbreviated New Drug Application (Generic) · Sponsor: PLD ACQUISITIONS LLC · Approved 2024-04-11
## Drug
- **FDA Application Number:** ANDA211404
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IBUPROFEN AND DIPHENHYDRAMINE CITRATE
- **Generic name:** IBUPROFEN, DIPHENHYDRAMINE CITRATE
- **Active ingredients:** DIPHENHYDRAMINE CITRATE; IBUPROFEN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** PLD ACQUISITIONS LLC
- **Manufacturer:** PLD Acquisitions LLC DBA Avma Pharma Solutions
- **First approval:** 2024-04-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211404)
---
*AI Analytics · CC0 1.0*